TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Dermacell AB
Closing information (x1000 NOK)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
4,048
|
3,224
|
2,825 |
| Financial expenses |
24
|
4
|
11 |
| Earnings before taxes |
55
|
-168
|
12 |
| EBITDA |
118
|
-126
|
61 |
| Total assets |
1,075
|
692
|
746 |
| Current assets |
1,058
|
636
|
653 |
| Current liabilities |
685
|
244
|
130 |
| Equity capital |
210
|
444
|
568 |
| - share capital |
52
|
49
|
48 |
| Employees (average) |
5
|
5
|
4 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
19.5%
|
64.2%
|
76.1% |
| Turnover per employee |
810
|
645
|
706 |
| Profit as a percentage of turnover |
1.4%
|
-5.2%
|
0.4% |
| Return on assets (ROA) |
7.3%
|
-23.7%
|
3.1% |
| Current ratio |
154.5%
|
260.7%
|
502.3% |
| Return on equity (ROE) |
26.2%
|
-37.8%
|
2.1% |
| Change turnover |
624
|
335
|
361 |
| Change turnover % |
18%
|
12%
|
15% |
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % |
0%
|
25%
|
0% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.